| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Oct 18, 2024 | Sale | $30.00 | 847 | 25,413 | 1,015,188 | Oct 22, 2024, 04:22 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Oct 09, 2024 | Sale | $28.16 | 37,878 | 1,066,561 | 1,019,624 | Oct 10, 2024, 08:39 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Oct 08, 2024 | Sale | $27.97 | 13,267 | 371,024 | 1,054,013 | Oct 10, 2024, 08:39 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Oct 04, 2024 | Sale | $27.51 | 7,522 | 206,937 | 1,069,887 | Oct 08, 2024, 06:58 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Oct 07, 2024 | Sale | $27.61 | 2,707 | 74,727 | 1,067,180 | Oct 08, 2024, 06:58 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Oct 01, 2024 | Sale | $27.54 | 527 | 14,512 | 1,077,409 | Oct 03, 2024, 06:47 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Aug 29, 2024 | Sale | $22.49 | 12,000 | 269,841 | 1,077,986 | Sep 03, 2024, 05:43 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Jul 31, 2024 | Sale | $27.56 | 3,099 | 85,399 | 1,089,936 | Aug 02, 2024, 07:26 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Jul 29, 2024 | Sale | $26.70 | 12,000 | 320,378 | 1,093,238 | Jul 31, 2024, 07:33 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Jul 01, 2024 | Sale | $22.89 | 12,000 | 274,736 | 1,105,035 | Jul 03, 2024, 04:31 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | May 29, 2024 | Option Exercise | $1.12 | 12,000 | 13,440 | 12,000 | May 31, 2024, 04:05 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | May 29, 2024 | Sale | $21.73 | 12,000 | 260,800 | 2,123 | May 31, 2024, 04:05 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Apr 29, 2024 | Sale | $17.92 | 12,000 | 214,988 | 1,013 | May 01, 2024, 07:04 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Apr 29, 2024 | Option Exercise | $1.12 | 12,000 | 13,440 | 12,000 | May 01, 2024, 07:04 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Apr 11, 2024 | Option Exercise | $1.12 | 30,000 | 33,600 | 30,000 | Apr 15, 2024, 07:06 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Apr 11, 2024 | Sale | $25.04 | 30,000 | 751,332 | 0 | Apr 15, 2024, 07:06 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Apr 01, 2024 | Option Exercise | $1.12 | 12,000 | 13,440 | 12,000 | Apr 03, 2024, 09:30 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Apr 01, 2024 | Sale | $18.60 | 12,000 | 223,146 | 9,648 | Apr 03, 2024, 09:30 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Feb 29, 2024 | Option Exercise | $1.12 | 12,000 | 13,440 | 12,000 | Mar 04, 2024, 05:55 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Feb 29, 2024 | Sale | $16.42 | 12,000 | 197,006 | 1,805 | Mar 04, 2024, 05:55 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Jan 29, 2024 | Option Exercise | $1.12 | 12,000 | 13,440 | 12,000 | Jan 31, 2024, 09:22 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Jan 29, 2024 | Sale | $15.85 | 12,000 | 190,256 | 0 | Jan 31, 2024, 09:22 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Dec 29, 2023 | Option Exercise | $1.12 | 12,000 | 13,440 | 12,000 | Jan 03, 2024, 07:01 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Dec 29, 2023 | Sale | $14.28 | 12,000 | 171,381 | 2,849 | Jan 03, 2024, 07:01 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Dec 21, 2023 | Option Exercise | $1.12 | 20 | 22 | 20 | Dec 26, 2023, 07:32 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Dec 21, 2023 | Sale | $13.00 | 20 | 260 | 0 | Dec 26, 2023, 07:32 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Dec 22, 2023 | Option Exercise | $1.12 | 6,546 | 7,332 | 6,546 | Dec 26, 2023, 07:32 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Dec 22, 2023 | Sale | $13.07 | 6,546 | 85,530 | 0 | Dec 26, 2023, 07:32 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Dec 20, 2023 | Sale | $13.01 | 8,688 | 113,046 | 0 | Dec 21, 2023, 04:29 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Dec 19, 2023 | Option Exercise | $1.12 | 200 | 224 | 200 | Dec 21, 2023, 04:29 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Dec 19, 2023 | Sale | $13.00 | 200 | 2,600 | 0 | Dec 21, 2023, 04:29 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Dec 20, 2023 | Option Exercise | $1.12 | 8,688 | 9,731 | 8,688 | Dec 21, 2023, 04:29 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Nov 03, 2023 | Option Exercise | $1.12 | 8,546 | 9,572 | 8,546 | Nov 06, 2023, 04:43 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Nov 03, 2023 | Sale | $13.08 | 8,546 | 111,751 | 0 | Nov 06, 2023, 04:43 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Sep 29, 2023 | Option Exercise | $1.12 | 12,000 | 13,440 | 12,000 | Oct 03, 2023, 07:40 PM | |
| ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Sep 29, 2023 | Sale | $13.62 | 12,000 | 163,498 | 0 | Oct 03, 2023, 07:40 PM |
Menu